Literature DB >> 15998375

KIT expression in normal and neoplastic renal tissues: immunohistochemical and molecular genetic analysis.

Noriko Kato1, Keiichi Honma, Hiroshi Hojo, Shun-Ichi Sasou, Osamu Matsuzaki, Teiichi Motoyama.   

Abstract

Renal chromophobe cell carcinomas (ChCC) and oncocytomas express KIT. This character seems to reflect their common histogenesis from distal nephrons. In the normal kidney, however, the expression and localization of KIT are unclear. KIT expression in angiomyolipoma and congenital mesoblastic nephroma (CMN), is still controversial. c-kit mutations are reportedly rare in ChCC, but there is little information in other renal neoplasms, and no reported data on mutations of platelet-derived growth factor receptor (PDGFR). In order to address these issues the authors examined five ChCC, five oncocytomas, seven papillary cell carcinomas, two collecting duct carcinomas, 12 angiomyolipomas, and three CMN, as well as 10 normal renal tissues. In the normal kidney KIT was specifically expressed in the distal nephrons. Nine of 12 (75%) angiomyolipomas contained scattered KIT-positive cells, whereas all three CMN were completely negative for KIT. The presence of KIT-positive cells in angiomyolipomas was likely to correspond to that of melanocytic marker-positive cells, which mainly showed epithelioid morphology. Polymerase chain reaction-single-strand conformation polymorphism showed no evidence of mutations of c-kit or PDGFR in any of the tumors examined.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15998375     DOI: 10.1111/j.1440-1827.2005.01856.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  4 in total

1.  Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.

Authors:  Jay Amin; Bo Xu; Shervin Badkhshan; Terrance T Creighton; Daniel Abbotoy; Christine Murekeyisoni; Kristopher M Attwood; Thomas Schwaab; Craig Hendler; Michael Petroziello; Charles L Roche; Eric C Kauffman
Journal:  Clin Cancer Res       Date:  2018-05-11       Impact factor: 12.531

2.  KIT, PDGFRalpha and EGFR analysis in nephroblastoma.

Authors:  Sylvia C Wetli; Ivo Leuschner; Dieter Harms; Alex Rufle; Anja Foerster; Michel Bihl; Norbert Graf; Roikos Furtwaengler; Michael Paulussen; Jakob Briner; Charalampos Aslanidis; Gerd Schmitz; Luigi Tornillo; Michael J Mihatsch; Inti Zlobec; Elisabeth Bruder
Journal:  Virchows Arch       Date:  2008-05-14       Impact factor: 4.064

3.  Nephrogenic adenoma of the urinary tract: clinical, histological, and immunohistochemical characteristics.

Authors:  José I López; Marco Schiavo-Lena; Alexandra Corominas-Cishek; Adriana Yagüe; Kevin Bauleth; Rosa Guarch; Ondrej Hes; Regina Tardanico
Journal:  Virchows Arch       Date:  2013-10-19       Impact factor: 4.064

4.  Stem cell factor expression after renal ischemia promotes tubular epithelial survival.

Authors:  Geurt Stokman; Ingrid Stroo; Nike Claessen; Gwendoline J D Teske; Jan J Weening; Jaklien C Leemans; Sandrine Florquin
Journal:  PLoS One       Date:  2010-12-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.